欢迎使用我们的服务！
限时优惠，立即购买享受折扣
24小时客服在线，随时为您服务
优质产品，值得信赖

印度仿制药专卖店
登录
顶 置

文章列表

Press release (on il Sole 24 Ore) – Interim Report First Half (as at 30 June 2026)

2026-08-10
Recent And Upcoming US FDA Advisory Committee Meetings

2026-08-10
RECORDATI: PUBLICATION OF THE INTERIM REPORT FIRST HALF (AS AT 30.06.2026)

2026-08-09
Aurobindo Receives FDA Approval for Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5%

2026-08-09
EU Urged To Reject ‘Industrially Unviable’ Export Restrictions

2026-08-09
Is European Withdrawal Of Tavneos The Start Of A Global Regulatory Reckoning?

2026-08-09
Application-Manager (80 - 100%)

2026-08-09
SMID Cap Earnings In Brief: Sarepta, Arcturus, Iovance, BioMarin, Viridian & Roivant

2026-08-08
IPF Pipeline’s Next Big Readout: Bristol’s Admilparant Pivotal Trial

2026-08-08
Bristol Myers Squibb Reports Second Quarter Financial Results for 2026

2026-08-08
EU Urged To Reject ‘Industrially Unviable’ Export Restrictions

2026-08-08
Is European Withdrawal Of Tavneos The Start Of A Global Regulatory Reckoning?

2026-08-08